Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8102, Japan.
Department of Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Stem Cell Res Ther. 2024 Aug 26;15(1):269. doi: 10.1186/s13287-024-03877-z.
Liver disease imposes a significant medical burden that persists due to a shortage of liver donors and an incomplete understanding of liver disease progression. Hepatobiliary organoids (HBOs) could provide an in vitro mini-organ model to increase the understanding of the liver and may benefit the development of regenerative medicine.
In this study, we aimed to establish HBOs with bile duct (BD) structures and mature hepatocytes (MHs) using human chemically induced liver progenitor cells (hCLiPs). hCLiPs were induced in mature cryo-hepatocytes using a small-molecule cocktail of TGF-β inhibitor (A-83-01, A), GSK3 inhibitor (CHIR99021, C), and 10% FBS (FAC). HBOs were then formed by seeding hCLiPs into ultralow attachment plates and culturing them with a combination of small molecules of Rock-inhibitor (Y-27632) and AC (YAC).
These HBOs exhibited bile canaliculi of MHs connected to BD structures, mimicking bile secretion and transportation functions of the liver. The organoids showed gene expression patterns consistent with both MHs and BD structures, and functional assays confirmed their ability to transport the bile analogs of rhodamine-123 and CLF. Functional patient-specific HBOs were also successfully created from hCLiPs sourced from cirrhotic liver tissues.
This study demonstrated the potential of human HBOs as an efficient model for studying hepatobiliary diseases, drug discovery, and personalized medicine.
肝脏疾病造成了巨大的医疗负担,这是由于肝源短缺和对肝脏疾病进展认识不足造成的。肝胆类器官(HBOs)可以提供一种体外微型器官模型,以增加对肝脏的了解,并可能有益于再生医学的发展。
在这项研究中,我们旨在使用人化学诱导的肝祖细胞(hCLiPs)建立具有胆管(BD)结构和成熟肝细胞(MHs)的 HBOs。使用 TGF-β抑制剂(A-83-01,A)、GSK3 抑制剂(CHIR99021,C)和 10% FBS(FAC)的小分子鸡尾酒将 hCLiPs 诱导至成熟冷冻保存的肝细胞中。然后,通过将 hCLiPs 接种到超低附着平板中,并使用 Rock 抑制剂(Y-27632)和 AC(YAC)的小分子混合物培养它们,形成 HBOs。
这些 HBOs 表现出与 MHs 相连的 BD 结构的胆管腔,模拟了肝脏的胆汁分泌和运输功能。类器官表现出与 MHs 和 BD 结构一致的基因表达模式,功能测定证实了它们运输 rhodamine-123 和 CLF 等胆汁类似物的能力。还成功地从源自肝硬化肝组织的 hCLiPs 中创建了功能性患者特异性 HBOs。
这项研究表明,人类 HBOs 作为研究肝胆疾病、药物发现和个性化医学的有效模型具有潜力。